BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27929143)

  • 1. Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.
    Wang B; Xu M; Zheng K; Yu X
    Sci Rep; 2016 Dec; 6():38783. PubMed ID: 27929143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
    Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels.
    Fujiwara T; Medellin MR; Sambri A; Tsuda Y; Balko J; Sumathi V; Gregory J; Jeys L; Abudu A
    Bone Joint J; 2019 Aug; 101-B(8):1024-1031. PubMed ID: 31362545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.
    Paludo J; Fritchie K; Haddox CL; Rose PS; Arndt CAS; Marks RS; Galanis E; Okuno SH; Robinson SI
    Am J Clin Oncol; 2018 Sep; 41(9):832-837. PubMed ID: 28622153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
    Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
    Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    Xu M; Xu S; Yu X
    World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
    Xie L; Guo W; Li Y; Ji T; Sun X
    J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limb-salvage surgery in 60 patients with osteosarcoma].
    Ma Z; Li H; Gao S
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):82-5. PubMed ID: 7656710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone primary sarcomas undergone unplanned intralesional procedures - the possibility of limb salvage and their oncologic results.
    Jeon DG; Lee SY; Kim JW
    J Surg Oncol; 2006 Dec; 94(7):592-8. PubMed ID: 17066433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
    Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
    Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
    Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local growth and the prognosis of osteosarcoma.
    Wuisman P; Enneking WF; Roesner A
    Int Orthop; 1992; 16(1):55-8. PubMed ID: 1572772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma of the jaws: factors influencing prognosis.
    Granowski-LeCornu M; Chuang SK; Kaban LB; August M
    J Oral Maxillofac Surg; 2011 Sep; 69(9):2368-75. PubMed ID: 21288615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary high-grade osteosarcoma: comparison between preadolescent and older patients.
    Bacci G; Longhi A; Bertoni F; Bacchini P; Ruggeri P; Versari M; Picci P
    J Pediatr Hematol Oncol; 2005 Mar; 27(3):129-34. PubMed ID: 15750443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.